Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Sizzling DOAC Market - 3: Dosage and Administration Vary by Product for PE/DVT Treatment
August 26, 2016
- Sizzling DOAC Market - 2: Makers Accumulating Data from Actual Clinical Settings to Support Proper Use
August 25, 2016
- Announcement: Real World Data Japan 2016 to Be Held at Westin Tokyo Hotel on October 18-19
August 25, 2016
- Sizzling DOAC Market - 1: Japan Sales Reaching 140 Billion Yen on 4-Way Fight
August 24, 2016
- Canaglu-Tenelia Combo Filed in Japan: Mitsubishi Tanabe
August 23, 2016
- GSK Paid 6.2 Billion Yen to Doctors, Medical Institutions in 2015
August 23, 2016
- New Treatment Options Arriving in Multiple Myeloma Arena
August 23, 2016
- Sales per Drug Rep Check in at 168 Million Yen in FY2015: Survey
August 22, 2016
- Oncolys to Set Up US Subsidiary to Ratchet Up Licensing Activities
August 22, 2016
- Evidence for Actair Sublingual Tablets “Sets It Apart from Other Therapies”: Shionogi
August 22, 2016
- Oncolys, Kyoto Pref. University of Medicine to Study OBP-801 for Glaucoma
August 19, 2016
- Amgen Confident of Getting Handsome Slice of Japan Biosimilar Market: Exec
August 19, 2016
- CEO of Teva-Takeda JV Confident on Handling Both Long-Listed Brands, Generics
August 17, 2016
- Ethical Drug Sales Down 0.8% in June: Crecon Report
August 17, 2016
- Mitsubishi Tanabe to Focus on Sales Turnaround for Canaglu, Eyes Diabetes and Nephrology Sales of 100 Bil. Yen
August 17, 2016
- Taiho Phama Subsidiary Gets Approval for Uzel AG
August 16, 2016
- Japan NDA Filed for Gilead’s HIV Drug Descovy
August 16, 2016
- Oncolys, NCC Hospital East to Run Investigator-Led Trial on Oncolytic Virus
August 15, 2016
- AnGes MG, Vical to Form Biz Tie-Up over DNA Vaccines
August 15, 2016
- Shionogi Begins Distribution of Ethical Isodine Products: Mundipharma
August 15, 2016
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…